Literature DB >> 17760557

Rhabdomyosarcoma of the maxillary gingiva.

Angela C Chi1, Jeffrey D Barnes, Steven Budnick, Samuel V Agresta, Brad Neville.   

Abstract

BACKGROUND: Rhabdomyosarcoma is a malignant neoplasm of primitive mesenchyme exhibiting skeletal muscle differentiation. Oral rhabdomyosarcoma is rare and accounts for only 0.04% of all head and neck malignancies.
METHODS: A 33-year-old woman presented with an erythematous gingival mass involving the anterior maxillary gingiva. The lesion had been present for > or =13 months before presentation, and in recent months, it had become intermittently painful.
RESULTS: Clinical examination exhibited erythema and enlargement of the interdental papillae between the left maxillary canine, lateral incisor, and central incisor. The tissue was boggy and tender on palpation. Incisional biopsies were performed, and microscopic examination showed a cellular proliferation of spindle-shaped to ovoid cells with hyperchromatic, enlarged, and pleomorphic nuclei. Many of the tumor cells exhibited abundant eosinophilic cytoplasm. Immunohistochemical stains showed the tumor cells to be positive for desmin, myogenin, and myogenic differentiation 1 (MyoD1). A diagnosis of embryonal rhabdomyosarcoma was made. The patient was treated by surgical resection with postoperative chemotherapy and radiation. The patient had no evidence of disease at a follow-up examination 1 month after completion of therapy.
CONCLUSIONS: Oral rhabdomyosarcoma can develop insidiously. Pain is a variable presenting symptom, and early lesions may be mistaken for benign neoplastic, inflammatory, or infectious processes. Over several decades, a multidisciplinary treatment approach that includes surgical removal if resectable, in combination with multiagent chemotherapy and possibly radiation therapy, has improved survival rates.

Entities:  

Mesh:

Year:  2007        PMID: 17760557     DOI: 10.1902/jop.2007.060454

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  9 in total

1.  Clinico-pathologic conference: case 2. Embryonal rhabdomyosarcoma (RMS).

Authors:  Camilla Kragelund; Shabnum Meer; Lars Pallesen; Jesper Reibel
Journal:  Head Neck Pathol       Date:  2010-11-13

2.  Embryonal rhabdomyosarcoma occurring on mandibular gingiva in an adult.

Authors:  Gururaj Patil; Sangamesh Halawar; Shitalkumar Sagari; Roopa Babannavar; Sharad Purohit
Journal:  J Clin Diagn Res       Date:  2013-09-10

3.  Rare tumors of sinonasal track.

Authors:  Darshan V Doshi; Umank Tripathi; Rajendra I Dave; Shashank J Pandya; Hemant K Shukla; Bhavana C Parikh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-09-24

4.  Embryonal Rhabdomyosarcoma (Botryoid Subtype) Affecting the Buccal Mucosa.

Authors:  John Lennon Silva Cunha; Francisco De Assis Almeida Lima-Júnior; Wilson Déda Gonçalves Júnior; Thiago De Santana Santos; Ericka Janine Dantas Da Silveira; Silvia Ferreira De Sousa; Ricardo Luiz Cavalcanti De Albuquerque-Júnior
Journal:  Head Neck Pathol       Date:  2018-08-09

Review 5.  Oral rhabdomyosarcoma: A review.

Authors:  Ankita Tandon; Kanika Sethi; Anand Pratap Singh
Journal:  J Clin Exp Dent       Date:  2012-12-01

6.  Rhabdomyosarcoma in a pediatric patient: A rare case report.

Authors:  S P Shrutha; G B Vinit
Journal:  Contemp Clin Dent       Date:  2015 Jan-Mar

7.  Rhabdomyosarcoma of the maxillary gingiva.

Authors:  Mina Motallebnejad; Pouyan Aminishakib; Samira Derakhshan; Abbas Karimi
Journal:  Dent Res J (Isfahan)       Date:  2018 Jan-Feb

8.  An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report.

Authors:  Stefan Hartmann; Grit Lessner; Thomas Mentzel; Alexander C Kübler; Urs D A Müller-Richter
Journal:  J Med Case Rep       Date:  2014-06-19

9.  Rhabdomyosarcoma in the maxillary gingiva of a child patient.

Authors:  Yuko Komatsu; Tadashi Kawai; Shoko Miura; Yasunori Takeda; Hiroyuki Yamada
Journal:  J Surg Case Rep       Date:  2021-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.